Radiofrequency ablation for liver: Comparison between expert eye and hyperspectral imaging assessment
Ramy Abdlaty1, Mohamed A Abbass1, Ahmed M Awadallah1
1Department of Biomedical Engineering, Military Technical College, Cairo, Egypt.
Photodiagnosis and Photodynamic Therapy
|December 23, 2021
Summary
Hyperspectral imaging (HSI) offers an objective method for assessing radiofrequency (RF) ablation in liver cancer treatment. Optimizing HSI by focusing on specific spectral bands, like 630 nm, reduces analysis time for safer, faster medical decisions.
Area of Science:
- Medical Physics
- Oncology
- Medical Imaging
Background:
- Liver/hepatic cancer (HC) affects 10% of global cancer patients, causing significant mortality.
- Radiofrequency (RF) ablation is a key thermal ablation technique for HC treatment.
- Current visual assessment (VA) of RF ablation outcomes is subjective and unreliable.
Purpose of the Study:
- To introduce hyperspectral imaging (HSI) as an objective method for evaluating liver ablation.
- To reduce the time-intensive nature of HSI data analysis for clinical application.
- To enhance the safety and speed of medical decisions regarding RF ablation continuation or cessation.
Main Methods:
- Computed ablated liver area using both visual assessment (VA) and hyperspectral imaging (HSI).
- Developed a method to reduce HSI data analysis time by narrowing spectral bands.
- Identified relevant spectral bands sensitive to changes in liver chromophore concentration post-ablation.
Main Results:
- Hyperspectral imaging (HSI) provides objective assessment of liver ablation, unlike subjective VA.
- Focused analysis on specific spectral bands significantly reduces HSI data processing time.
- The spectral band centered at 630 nm was identified as optimal for objective assessment.
Conclusions:
- Hyperspectral imaging (HSI) offers a viable, objective alternative to VA for liver ablation assessment.
- Optimized HSI analysis, particularly using the 630 nm band, enables faster clinical decision-making.
- This approach supports safer and more efficient RF ablation treatment for liver cancer.


